Drug class
Renin Inhibitors, Direct
Direct renin inhibitors are a pharmacologic class of cardiovascular agents used primarily for the management of essential hypertension. Read more about Renin Inhibitors, Direct
4 drugs in this class 4 manufacturers
Drugs in Renin Inhibitors, Direct
ALISKIREN (aliskiren hemifumarate)
TEKTURNA (aliskiren hemifumarate)
TEKTURNA (aliskiren hemifumarate)
Direct renin inhibitors are a pharmacologic class of cardiovascular agents used primarily for the management of essential hypertension.
These medications work by selectively binding to the active enzymatic site of renin, thereby blocking the rate-limiting step of the renin-angiotensin-aldosterone system that converts angiotensinogen into angiotensin I.
By preventing the downstream formation of angiotensin II and aldosterone, direct renin inhibitors promote vasodilation and reduce systemic vascular resistance, ultimately lowering arterial blood pressure.
Aliskiren is the representative agent in this drug class, typically utilized as monotherapy or in combination with other select antihypertensive therapies.
-
fda.gov
Direct renin inhibitors are a pharmacologic class of cardiovascular agents used primarily for the management of essential hypertension These medications work by selectively binding to the active enzymatic site of renin, thereby blocking the rate-limiting step of the renin-angiotensin-aldosterone system that converts angiotensinogen into angiotensin I. By preventing the downstream formation of angiotensin II and aldosterone, direct renin inhibitors promote vasodilation and reduce systemic vascula...
-
fda.gov
Direct renin inhibitors are a pharmacologic class of cardiovascular agents used primarily for the management of essential hypertension Aliskiren is the representative agent in this drug class, typically utilized as monotherapy or in combination with other select antihypertensive therapies
-
fda.gov
These medications work by selectively binding to the active enzymatic site of renin, thereby blocking the rate-limiting step of the renin-angiotensin-aldosterone system that converts angiotensinogen into angiotensin I These medications work by selectively binding to the active enzymatic site of renin, thereby blocking the rate-limiting step of the renin-angiotensin-aldosterone system that converts angiotensinogen into angiotensin I. By preventing the downstream formation of angiotensin II and al...
-
nih.gov
These medications work by selectively binding to the active enzymatic site of renin, thereby blocking the rate-limiting step of the renin-angiotensin-aldosterone system that converts angiotensinogen into angiotensin I
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.